Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Extended treatment continued to limit body weight gain and white adipose tissue mass, lowered total plasma cholesterol, and showed measurable accumulation in adipose tissue consistent with the compounds lipophilic profile
What Is AOD 9604 Peptide and Why Is It Generating Clinical Interest
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
These compounds are not FDAapproved for general consumer use, retail sale, or recreational selfadministration, and are not marketed or sold by our clinic for unsupervised consumption
We use a strict sterile technique, cleaning the site with a medical-grade alcohol swab to ensure everything is safe and sanitary
